Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C.

C P Cheney1, S Chopra, C Graham

  • 1Harvard Medical School, Division of Gastroenterology, Boston, Massachusetts, USA.

Infectious Disease Clinics of North America
|September 15, 2000
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) is a leading cause of chronic liver disease. Research since 1989 has significantly advanced understanding and treatment of HCV, with future options expected to improve further.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DOSET: dose optimization with simultaneous efficacy and toxicity evaluation, motivated by a first-in-human phase I CAR T lymphoma trial.

ESMO open·2026
Same author

A rapid review of periviable (22 + 0 to 23 + 6 weeks) counselling practices and the need for a trauma-informed care approach.

Frontiers in pediatrics·2025
Same author

Patient experience preparing for prostate cancer radiotherapy.

Technical innovations & patient support in radiation oncology·2025
Same author

Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.

Bone marrow transplantation·2024
Same author

Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.

Contemporary clinical trials·2024
Same author

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) became the most prevalent cause of chronic liver disease in the late 20th century.
  • HCV remains a significant global health concern.
  • Understanding of HCV has grown substantially since its discovery.

Purpose of the Study:

  • To review the progress in understanding Hepatitis C virus.
  • To highlight advancements in diagnosis and treatment of HCV.
  • To project future developments in HCV therapeutics.

Main Methods:

  • Literature review of HCV research.
  • Analysis of epidemiological data.
  • Synthesis of virological and clinical findings.

Related Experiment Videos

Main Results:

  • Significant advancements in virology, epidemiology, natural history, diagnosis, and treatment of HCV.
  • HCV identified as the primary cause of chronic liver disease.
  • Ongoing research promises improved treatment options.

Conclusions:

  • Hepatitis C virus (HCV) is a major cause of chronic liver disease.
  • Rapid scientific progress has been made in understanding and managing HCV.
  • Future therapeutic advancements are anticipated for superior patient outcomes.